As of 2026-03-15, the Relative Valuation of Anika Therapeutics Inc (ANIK) is (48.91) USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.20 USD, the upside of Anika Therapeutics Inc based on Relative Valuation is -444.5%.
The range of the Relative Valuation is (41.74) - (52.05) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 23.8x | 21.1x |
| Forward P/E multiples | 17.0x - 22.7x | 21.6x |
| Fair Price | (41.74) - (52.05) | (48.91) |
| Upside | -394.0% - -466.6% | -444.5% |
| Date | P/E |
| 2026-03-13 | -6.19 |
| 2026-03-12 | -6.24 |
| 2026-03-11 | -6.27 |
| 2026-03-10 | -6.31 |
| 2026-03-09 | -6.53 |
| 2026-03-06 | -6.16 |
| 2026-03-05 | -6.22 |
| 2026-03-04 | -6.27 |
| 2026-03-03 | -6.29 |
| 2026-03-02 | -6.25 |
| 2026-02-27 | -6.27 |
| 2026-02-26 | -5.58 |
| 2026-02-25 | -4.78 |
| 2026-02-24 | -4.74 |
| 2026-02-23 | -4.77 |
| 2026-02-20 | -4.64 |
| 2026-02-19 | -4.67 |
| 2026-02-18 | -4.59 |
| 2026-02-17 | -4.55 |
| 2026-02-13 | -4.46 |
| 2026-02-12 | -4.39 |
| 2026-02-11 | -4.47 |
| 2026-02-10 | -4.51 |
| 2026-02-09 | -4.47 |
| 2026-02-06 | -4.57 |
| 2026-02-05 | -4.50 |
| 2026-02-04 | -4.66 |
| 2026-02-03 | -4.37 |
| 2026-02-02 | -4.20 |
| 2026-01-30 | -4.03 |
| 2026-01-29 | -3.99 |
| 2026-01-28 | -3.99 |
| 2026-01-27 | -3.99 |
| 2026-01-26 | -4.03 |
| 2026-01-23 | -4.06 |
| 2026-01-22 | -4.10 |
| 2026-01-21 | -4.16 |
| 2026-01-20 | -4.13 |
| 2026-01-16 | -4.06 |
| 2026-01-15 | -4.16 |
| 2026-01-14 | -4.16 |
| 2026-01-13 | -4.17 |
| 2026-01-12 | -4.11 |
| 2026-01-09 | -4.16 |
| 2026-01-08 | -4.17 |
| 2026-01-07 | -4.29 |
| 2026-01-06 | -4.22 |
| 2026-01-05 | -4.13 |
| 2026-01-02 | -4.08 |
| 2025-12-31 | -4.19 |